Anemia of prematurity affects the majority of preterm infants, particularly extremely low birthweight infants. Anemia of prematurity arises from both innate and iatrogenic causes and results in more than 80% of extremely preterm infants receiving red blood cell transfusions during the first month after birth. Multiple randomized controlled trials were conducted to evaluate the effect of using lower versus higher transfusion thresholds based on hemoglobin levels. These trials showed no difference in the primary outcome of neurodevelopmental impairment at 2 years of age between lower and higher thresholds. However, some uncertainties about transfusion thresholds remain. This review elaborates the following: 1) the etiology, prevention, and treatment of anemia of prematurity with a focus on red blood cell transfusions, 2) the history of randomized controlled trials on the treatment of anemia of prematurity, and 3) limitations of the evidence and remaining questions about thresholds for red blood cell transfusions in preterm infants.
Skip Nav Destination
Article navigation
June 2023
Article|
June 01 2023
Red Blood Cell Transfusion Thresholds for Anemia of Prematurity
Lindsay F. Holzapfel, MD, MS;
Lindsay F. Holzapfel, MD, MS
*McGovern Medical School at University of Texas Health Science Center, Houston, TX
†Children’s Memorial Hermann Hospital, Houston, TX
Search for other works by this author on:
Matthew A. Rysavy, MD, PhD;
Matthew A. Rysavy, MD, PhD
*McGovern Medical School at University of Texas Health Science Center, Houston, TX
†Children’s Memorial Hermann Hospital, Houston, TX
Search for other works by this author on:
Edward F. Bell, MD
Edward F. Bell, MD
‡University of Iowa, Iowa City, IA
Search for other works by this author on:
Neoreviews (2023) 24 (6): e370–e376.
Citation
Lindsay F. Holzapfel, Matthew A. Rysavy, Edward F. Bell; Red Blood Cell Transfusion Thresholds for Anemia of Prematurity. Neoreviews June 2023; 24 (6): e370–e376. https://doi.org/10.1542/neo.24-6-e370
Download citation file:
Comments